Ignite Creation Date:
2025-12-24 @ 11:20 PM
Ignite Modification Date:
2026-02-22 @ 3:56 PM
Study NCT ID:
NCT04158856
Status:
NOT_YET_RECRUITING
Last Update Posted:
2019-11-12
First Post:
2019-11-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Adjuvant Dual Anti-HER2 Therapy in Patients With Small, Node-negative, HER2-positive Breast Cancer
Sponsor:
xuexin he
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-06-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2023-05-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2030-05-31
Completion Date Type:
ESTIMATED
First Submit Date:
2019-11-07
First Submit QC Date:
None
Study First Post Date:
2019-11-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-11-07
Last Update Post Date:
2019-11-12
Last Update Post Date Type:
ACTUAL